Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-06-06

Clinical Trial Update: Phase II Clinical Study of TR-012001 in Japanese Patients With Parkinson's Disease [Phase 2]

View source ↗

Summary

Phase II clinical study of TR-012001 in Japanese patients with Parkinson disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TR-012001

Snippet

Sponsor: SNLD, Ltd. | Conditions: Parkinson Disease | Phase 2 | Status: COMPLETED